1. Home
  2. EVTC vs XNCR Comparison

EVTC vs XNCR Comparison

Compare EVTC & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$29.98

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$26.02

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTC
XNCR
Founded
1988
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
EVTC
XNCR
Price
$29.98
$26.02
Analyst Decision
Hold
Buy
Analyst Count
5
9
Target Price
$35.80
$22.33
AVG Volume (30 Days)
384.3K
1.2M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
0.67%
N/A
EPS Growth
27.17
65.36
EPS
0.47
N/A
Revenue
$453,869,000.00
$125,576,000.00
Revenue This Year
$12.68
N/A
Revenue Next Year
$6.86
$4.80
P/E Ratio
$62.70
N/A
Revenue Growth
11.48
13.65
52 Week Low
$21.81
$7.91
52 Week High
$35.41
$30.61

Technical Indicators

Market Signals
Indicator
EVTC
XNCR
Relative Strength Index (RSI) 49.38 71.57
Support Level $28.87 $11.20
Resistance Level $30.38 N/A
Average True Range (ATR) 0.93 1.35
MACD -0.17 0.22
Stochastic Oscillator 28.55 73.02

Price Performance

Historical Comparison
EVTC
XNCR

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: